Founded in 1887 in Clinton, New York, by William McLaren Bristol and John Ripley Myers, and later combined with the historic Squibb enterprise to form Bristol Myers Squibb in 1989, Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. Headquartered in Lawrenceville, New Jersey, the company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, neuroscience, and cell therapy. For the full-year 2025, Bristol Myers Squibb reported revenue of USD 48.2 billion and described its global workforce as more than 30,000 employees, supported by an extensive international network of research, development, manufacturing, and commercial operations.
Updated 2026-03-19